Lonza AG
Location
WALLIS
Founded
1897-12-07
Website
Risk Signals
2769 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial Organic Chemicals, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Lonza AG
Live alerts from global media, monitored by Business Radar
2025-08-14 (chemanager-online.com)
Arcinova Appoints Christian Dowdeswell as New Managing Director • CHEManager is the market-leading medium for the management of the chemical and pharmaceutical industry
Former Vice President and Global Head of Commercial Development of Lonza's small molecules custom manufacturing business to head up Arcinova, Quotient Sciences' CRDMO.
Read more
2025-08-06 (contractpharma.com)
Arcinova Names Christian Dowdeswell Managing Director |
Former Vice President and Global Head of Commercial Development of Lonza's small molecules custom manufacturing business to head up Arcinova.
Read more
2025-05-24 (vogel.de)
Important personnel changes in the chemical and process industry
Current personnel decisions and changes on supervisory boards, board members and management bodies summarized in the chemical and process industry.
Read more
2024-12-13 (stocktitan.net)
Heineken Holding Taps Lonza Chairman Jean-Marc Huët as New Board Chair in Major Leadership Shift | HKHHY Stock News
Heineken Holding announces key leadership transition as Jean-Marc Huët, current Lonza Chairman, set to succeed long-serving Chair Maarten Das in strategic board restructuring.
Read more
2024-12-13 (stocktitan.net)
Heineken Holding Taps Lonza Chairman Jean-Marc Huët as New Board Chair in Major Leadership Shift | HKHHY Stock News
Heineken Holding announces key leadership transition as Jean-Marc Huët, current Lonza Chairman, set to succeed long-serving Chair Maarten Das in strategic board restructuring.
Read more
2024-12-13 (stocktitan.net)
Heineken Holding Taps Lonza Chairman Jean-Marc Huët as New Board Chair in Major Leadership Shift | HKHHY Stock News
Heineken Holding announces key leadership transition as Jean-Marc Huët, current Lonza Chairman, set to succeed long-serving Chair Maarten Das in strategic board restructuring.
Read more
2024-12-09 (cash.ch)
New top jobs for the ex-Lonza boss | cash
Pierre-Alain Ruffieux is back in business. As a board member, but also as an operational manager.
Read more
2024-11-01 (hitnews.co.kr)
AGC Biologics appoints Alberto Santa Gostino as CEO
AGC Biologics (CEO Alberto Santagostino) announced on the 31st that it would appoint Alberto Santagostino as CEO and president. CEO Santagostino has been working in cell and gene therapy at Lonza for the past six years. He previously served as head of the (CGT) division. According to the company, during CEO Santa Gostino's tenure, the CGT business grew four-fold, and four new cell gene therapy products entered the commercial production stage. In addition, the CGT sector operation policy was changed to 'commercial production-oriented operation', and three CGT manufacturing plants began supplying commercial goods.
Read more
2024-11-01 (hitnews.co.kr)
AGC Biologics appoints Alberto Santa Gostino as CEO
AGC Biologics (CEO Alberto Santagostino) announced on the 31st that it would appoint Alberto Santagostino as CEO and president. CEO Santagostino has been working in cell and gene therapy at Lonza for the past six years. He previously served as head of the (CGT) division. According to the company, during CEO Santa Gostino's tenure, the CGT business grew four-fold, and four new cell gene therapy products entered the commercial production stage. In addition, the CGT sector operation policy was changed to 'commercial production-oriented operation', and three CGT manufacturing plants began supplying commercial goods.
Read more
2024-10-22 (themarket.ch)
With Lonza shares, those who are patient are rewarded
The shares of the world's largest contract manufacturer Lonza require a particularly long investment horizon. Despite their high valuation, they are worth buying even at the advanced price level; the long-term trends are in their favor.
Read more
2024-10-12 (farodevigo.es)
Zona Franca and Lonza open avenues of collaboration
The Free Trade Zone delegate, David Regades, received yesterday the new general director of Lonza Biologics, Fernando Rodríguez Martín, as the first contact between the two since the latter assumed his position at the head of the firm. Both agreed on the need to open avenues of collaboration.
Read more
2024-10-03 (laliberte.ch)
Pharmaceutical industry. Lonza proposes new member for the board of directors
Pharmaceutical industry supplier Lonza has proposed the appointment of a new member to the board of directors.
Read more